| abstract |
The invention concerns 5-cyano-1H-indole derivatives of formula (I), wherein: R1, R2, X and n are such as defined in Claim 1, as well as their pharmaceutically acceptable salts, solvates, and hydrates. The invention also concerns pharmaceutical compositions containing them, and their use for preparing medicines for preventive or curative treatment of diseases mediated by the activation of the CXCR2 receptor of interleukine-8 and chemokines of the same family. |